Patients undergoing TKI therapy are closely monitored for both efficacy and adverse effects. Regular blood tests, imaging studies, and molecular diagnostics are used to assess the response to treatment. Monitoring genetic mutations through techniques like next-generation sequencing can help in adjusting therapy and managing resistance.
